Nasopharyngeal carcinoma other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]Faizan Sheraz, M.D. [3]

Overview

Positron emission tomography (PET) scan may be helpful in the diagnosis of nasopharyngeal carcinoma. It is useful in the detection of residual or recurrent tumor after treatment and distant metastasis, prediction of clinical cancer outcome and PET/CT scan is used for NPC staging.

Other Imaging Studies

PET scan may be helpful in the diagnosis of nasopharyngeal carcinoma. PET scan is used for:^[1]^[2]^[3]^[4]

References

↑ Nakamoto, Yuji; Osman, Medhat; Wahl, Richard L. (2003). “Prevalence and Patterns of Bone Metastases Detected with Positron Emission Tomography Using F-18 FDG”. Clinical Nuclear Medicine. 28 (4): 302–307. doi:10.1097/01.RLU.0000057556.54046.7A. ISSN 0363-9762.
↑ Yen, Ruoh-Fang; Hung, Rey-Long; Pan, Mei-Hsiu; Wang, Yao-Hung; Huang, Kou-Mou; Lui, Louis T.; Kao, Chia-Hung (2003). “18-Fluoro-2-deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging”. Cancer. 98 (2): 283–287. doi:10.1002/cncr.11519. ISSN 0008-543X.
↑ Chang, K.-P.; Tsang, N.-M.; Liao, C.-T.; Hsu, C.-L.; Chung, M.-J.; Lo, C.-W.; Chan, S.-C.; Ng, S.-H.; Wang, H.-M.; Yen, T.-C. (2012). “Prognostic Significance of 18F-FDG PET Parameters and Plasma Epstein-Barr Virus DNA Load in Patients with Nasopharyngeal Carcinoma”. Journal of Nuclear Medicine. 53 (1): 21–28. doi:10.2967/jnumed.111.090696. ISSN 0161-5505.
↑ Yang, Zhongyi; Shi, Qi; Zhang, Yongping; Pan, Herong; Yao, Zhifeng; Hu, Silong; Shi, Wei; Zhu, Beiling; Zhang, Yingjian; Hu, Chaosu (2015). “Pretreatment 18 F-FDG uptake heterogeneity can predict survival in patients with locally advanced nasopharyngeal carcinoma——a retrospective study”. Radiation Oncology. 10 (1): 4. doi:10.1186/s13014-014-0268-5. ISSN 1748-717X.

Overview